15.9800.68% ( -0.110 )
Closed: Nov 16, 16:00:00 (EDT)Overview
Bambusa Therapeutics (BBTX)
Bambusa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops long-acting bispecific antibodies for the treatment of immunological and inflam...
- Open
- 16.360
- High
- 16.590
- Low
- 15.840
- Prev. Close
- 16.090
- Volume
- 139.85K
- Turnover
- 2.25M
- Avg Price
- 16.093
- Bid/Ask Ratio
- 69.23%
- Amplitude
- 4.66%
- 52wk High
- 17.652
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.49%
- 52wk Low
- 13.600
- Float Mkt Cap
- 149.81M
- Market CapUSD
- 795.19M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.979
- EPSDynamic
- -0.899
- EPSStatic
- --
- BVPS
- -1.43
- P/B
- --
- Circulating Supply
- 9.38M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 49.76M
- Min lot size
- 1
- Currency
- USD
News
Market Movers · Bambusa Therapeutics climbs 3% to 52-week high
Market Movers · Bambusa Therapeutics surges 8%
TradingView · Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics
Market Movers · Bambusa Therapeutics climbs 9%
PUBT · Bambusa Therapeutics Adopts Amended Bylaws Following IPO
